当前位置:首页 - 行情中心 - 药明康德(603259) - 财务分析 - 现金流量表

药明康德

(603259)

  

流通市值:2554.90亿  总市值:3048.91亿
流通股本:24.73亿   总股本:29.52亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金22,710,907,108.6110,887,895,827.6241,023,171,534.6929,359,129,012.71
  收到的税费返还812,228,117.9496,033,127.371,426,098,831.351,312,328,095.05
  收到其他与经营活动有关的现金532,873,783.14256,410,492.71,015,938,369.1575,390,065.07
  经营活动现金流入小计24,056,009,009.6511,640,339,447.6943,465,208,735.1431,246,847,172.83
  购买商品、接受劳务支付的现金8,617,574,553.833,720,501,702.7215,075,656,437.510,928,215,498.32
  支付给职工以及为职工支付的现金5,770,875,505.753,455,707,702.0710,752,651,632.338,183,330,993.39
  支付的各项税费1,342,576,723.44669,843,245.53,131,836,919.542,369,175,464.68
  支付其他与经营活动有关的现金894,000,694.93598,856,935.682,098,548,911.181,387,032,831.29
  经营活动现金流出小计16,625,027,477.958,444,909,585.9731,058,693,900.5522,867,754,787.68
  经营活动产生的现金流量净额7,430,981,531.73,195,429,861.7212,406,514,834.598,379,092,385.15
二、投资活动产生的现金流量:
  收回投资收到的现金6,847,023,306.042,801,642,393.5411,490,069,612.545,266,733,483.82
  取得投资收益收到的现金58,168,449.9520,004,957.84482,075,411.66242,713,508.52
  处置固定资产、无形资产和其他长期资产收回的现金净额9,375,735.071,678,587.4715,837,544.069,734,408.38
  处置子公司及其他营业单位收到的现金净额1,255,520,822.861,255,520,822.86--
  投资活动现金流入小计8,170,088,313.924,078,846,761.7111,987,982,568.265,519,181,400.72
  购建固定资产、无形资产和其他长期资产支付的现金2,101,763,801.59734,534,627.094,003,492,547.652,491,653,740.12
  投资支付的现金4,258,782,879.041,144,555,938.9513,502,667,147.366,221,744,533.73
  投资活动现金流出小计6,360,546,680.631,879,090,566.0417,506,159,695.018,713,398,273.85
  投资活动产生的现金流量净额1,809,541,633.292,199,756,195.67-5,518,177,126.75-3,194,216,873.13
三、筹资活动产生的现金流量:
  吸收投资收到的现金--196,427,943.8816,427,943.88
  取得借款收到的现金7,677,208,916.664,767,126,048.98,268,427,336.788,265,727,336.78
  发行债券收到的现金--3,521,497,254.53-
  筹资活动现金流入小计7,677,208,916.664,767,126,048.911,986,352,535.198,282,155,280.66
  偿还债务支付的现金5,222,657,871.553,408,720,026.728,470,159,769.436,957,913,214.43
  分配股利、利润或偿付利息支付的现金3,915,938,314.759,416,181.893,084,876,631.263,049,740,937.38
  其中:子公司支付给少数股东的股利、利润21,980,66415,830,160--
  支付其他与筹资活动有关的现金3,467,940,039.8262,953,208.744,263,506,782.534,179,385,606.75
  筹资活动现金流出小计12,606,536,226.073,531,089,417.3515,818,543,183.2214,187,039,758.56
  筹资活动产生的现金流量净额-4,929,327,309.411,236,036,631.55-3,832,190,648.03-5,904,884,477.9
四、汇率变动对现金及现金等价物的影响-203,423,250.66-61,078,422.61387,525,345.81-9,427,113.53
五、现金及现金等价物净增加额4,107,772,604.926,570,144,266.333,443,672,405.62-729,436,079.41
  加:期初现金及现金等价物余额13,444,711,217.6413,444,711,217.6410,001,038,812.0210,001,038,812.02
  期末现金及现金等价物余额17,552,483,822.5620,014,855,483.9713,444,711,217.649,271,602,732.61
补充资料:
  净利润8,660,348,120.54-9,567,739,539.18-
  资产减值准备321,420,123.36-1,236,257,969.76-
  固定资产和投资性房地产折旧1,527,089,686.4-2,372,311,085.1-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧1,527,089,686.4-2,372,311,085.1-
  无形资产摊销68,534,477.74-164,533,512.69-
  长期待摊费用摊销49,264,471.95-231,657,383.2-
  处置固定资产、无形资产和其他长期资产的损失12,844,822.74-36,063,443.51-
  固定资产报废损失2,485,850.82-6,234,193.27-
  公允价值变动损失182,183,014.07--186,957,574.92-
  财务费用522,731,890.77--428,033,421.6-
  投资损失-3,669,213,003.27--604,162,381.66-
  递延所得税-137,723,370.66--44,156,932.49-
  其中:递延所得税资产减少-69,001,444.91--90,765,548.73-
    递延所得税负债增加-68,721,925.75-46,608,616.24-
  存货的减少-1,800,680,510.95--914,170,842.65-
  经营性应收项目的减少657,038,345.86--779,189,585.3-
  经营性应付项目的增加515,774,644.13-767,141,307.65-
  其他212,203,859.97-366,914,923.65-
  现金的期末余额17,552,483,822.56-13,444,711,217.64-
  减:现金的期初余额13,444,711,217.64-10,001,038,812.02-
  现金及现金等价物的净增加额4,107,772,604.92-3,443,672,405.62-
公告日期2025-07-292025-04-292025-03-182024-10-29
审计意见(境内)标准无保留意见
TOP↑